🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The war on substance use has always focussed on the people who use drugs, rather than the root causes that lead to substance use. These disproportionately affect ATSI and inequity needs to be addressed. james ward UQ Poche Centre for Indigenous Health ASHM #hivaids2024

Looking forward to hearing from this great group of clinicians and researchers on clinical management among people with #HIV. Kicking off with Jason Ong MSHC Research The Alfred talking about anal cancer likelihood and screening in Australia. ASHM #HIVAIDS2024

Prof. Jenny Hoy Dept Infectious Diseases, The Alfred & Monash Uni describes an automated data ecosystem, used to provide feedback to clinicians via a dashboard that can be used to optimise comorbidity screening and care for people with #HIV The Alfred. #HIVAIDS2024 ASHM Related poster #3 in the hall!

A/Prof. Richard Gray from Kirby Institute, UNSW UNSW presenting updated data on Australian Cascade of #HIV care; fantastic progress on #UNAIDS targets now 92%-96.6%-97.5%. Work to be done on increasing diagnosis, and case finding. #HIVAIDS2024 ASHM

HIV-associated neurologic syndromes of CNS doi.org/10.1212/con.00…

Gonna give this thing a go… 🦋#IDSky Will hang here for a while, but not liking the dark direction this platform has taken; #freedomofspeech does not afford you the right to harm or manipulate the masses, without consequence.

The benefit of #GLP1 receptor agonists extends beyond just weight loss. ⬇️ Inflammation ⬇️ Blood pressure ⬆️ Plaque stability ⬇️ Circulating lipids/fats The 🫀 cardiovascular protection is in part weight-independent due to these protective factors. buff.ly/3ZqVU9f

The science and the people at #CROI2025 are 10/10.

You should be able to get the medicine you need without worrying about the cost.

Considerations for antiretroviral and rifamycin co-treatment in people with HIV doi.org/10.1016/S2352-…

An 𝐦𝐑𝐍𝐀 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 is an approach for triggering immune responses against a pathogen. Traditional vaccines use inactivated or weakened forms of a pathogen, or purified antigens from the pathogen, to trigger protective immune responses. With mRNA vaccines, nucleic acid is

In the PURPOSE 2 phase 3 trial, the incidence of HIV infection with twice-yearly lenacapavir was lower than both the background incidence and the incidence with emtricitabine–tenofovir disoproxil fumarate. Full trial results and Research Summary: nej.md/4fFWVzJ

New review article on management of S. aureus bacteraemia: jamanetwork.com/journals/jama/… JAMA Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)

Under Anthony Albanese and Australian Labor: - Inflation is down - Real wages and living standards are growing again - Unemployment is low - Debt is down - Interest rates are going down - Growth is rebounding solidly in our economy. #AusPol

Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva,Switzerland doi.org/10.1007/s15010…

SNAP/COLCEBA trial session starting now Steven Tong Joshua Davis Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 Staph aureus causes 1 million deaths per year worldwide. Less than 4.5k randomized in staph aureus bacteremia. Randomized care is better than random care. SNAP platform started on a napkin. #ESCMIDGlobal

Treatments for mpox are needed. In this trial in the Democratic Republic of Congo, tecovirimat did not lead to faster resolution of mpox lesions than placebo in patients with clade I MPXV infection. Read the full PALM007 trial results: nej.md/3Yy3u0C Editorial:

Wow! If anyone ever doubts the power of crowd sourcing, look at the vaccine RCT table that has been built already, in under 24 h! Unbelievable work by Jake Scott, MD Dr. Abhay Dand, Alejandro Diaz and Dr. Ali Sebastian Meza Vazquez! bradspellberg.com/vaccine-rcts

#IDTwitter